Gafter U, Kathpalia S, Zikos D, Lau K
Am J Physiol. 1986 Aug;251(2 Pt 2):F278-82. doi: 10.1152/ajprenal.1986.251.2.F278.
Calcium absorption by spontaneously hypertensive rats (SHR) was variably reported to be different from normotensive Wistar-Kyoto (WKY) controls. Furthermore, blunted responsiveness to the intestinal effects of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] has also been postulated. To evaluate this hypothesis, calcium fluxes were measured by the Ussing technique across duodenum and descending colon with or without prior 1,25(OH)2D3 treatment. Duodenal mucosal-to-serosal calcium flux (Jm----s) (44.9 vs. 52.4 nmol X cm-2 X h-1), serosal-to-mucosal flux (Js----m) (25.6 vs. 28.4 nmol X cm-2 X h-1), and net flux (Jnet) were comparable. 1,25(OH)2D3 increased duodenal Jm----s in both SHR and WKY groups (95.2 and 86.8 nmol X cm-2 X h-1). Js----m was lower in SHR (26.1 vs. 35.6 nmol X cm-2 X h-1, P less than 0.01), although the tendency for a higher Jnet in SHR (68.6 vs. 51.2 nmoles X cm-2 X h-1) was statistically insignificant. Short-circuit current was higher in the colon of SHR, both before and after 1,25(OH)2D3, suggesting increased sodium transport. Basal colonic Jnet was virtually zero in both groups but comparably increased by 1,25(OH)2D3 because of stimulation in only Jm----s. Prevention of hypertension by hydralazine since the 4th wk of age did not alter the findings compared with the hypertensive SHR, suggesting calcium transport rates were unaffected by hypertension. These data indicate that in vitro, duodenal, and colonic active calcium transport by the SHR is similar to WKY. Their normal responses to 1,25(OH)2D3 do not support the hypothesis of intestinal resistance.
自发性高血压大鼠(SHR)的钙吸收情况与血压正常的Wistar - Kyoto(WKY)对照相比,不同研究报告的结果存在差异。此外,也有人推测其对1,25 - 二羟基维生素D3 [1,25(OH)2D3] 的肠道效应反应迟钝。为了评估这一假设,采用Ussing技术测量了在给予或未给予1,25(OH)2D3预处理的情况下,十二指肠和降结肠的钙通量。十二指肠黏膜到浆膜的钙通量(Jm→s)(44.9对52.4 nmol×cm-2×h-1)、浆膜到黏膜的通量(Js→m)(25.6对28.4 nmol×cm-2×h-1)以及净通量(Jnet)在两组间相当。1,25(OH)2D3使SHR组和WKY组的十二指肠Jm→s均增加(分别为95.2和86.8 nmol×cm-2×h-1)。SHR组的Js→m较低(26.1对35.6 nmol×cm-2×h-1,P<0.01),尽管SHR组Jnet有升高趋势(68.6对51.2 nmoles×cm-2×h-1),但差异无统计学意义。在给予1,25(OH)2D3前后,SHR组结肠的短路电流均较高,提示钠转运增加。两组基础结肠Jnet实际上均为零,但由于仅Jm→s受到刺激,1,25(OH)2D3使两组的Jnet均相当增加。自4周龄起用肼屈嗪预防高血压,与高血压SHR组相比,并未改变研究结果,提示钙转运速率不受高血压影响。这些数据表明,在体外,SHR的十二指肠和结肠活性钙转运与WKY相似。它们对1,25(OH)2D3的正常反应不支持肠道抵抗的假设。